Developing technologies to unlock the therapeutic and research potential of human stem cells

New Biotechnology

Volumn 30, Issue 4, 2013, Pages 378-380

  Minger, Stephen L ^a  

^a GE Healthcare Life Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL-BASED THERAPY; FUTURE CHALLENGES; HUMAN EMBRYONIC STEM CELLS; REGENERATIVE MEDICINE; RESEARCH POTENTIAL; STEM CELL BIOLOGY; STEM CELL RESEARCH; TOOLS AND TECHNOLOGIES;

CYTOLOGY; DRUG PRODUCTS; HEALTH CARE; RESEARCH;

STEM CELLS;

ARTICLE; BIOTECHNOLOGY; CARDIOTOXICITY; CELL ASSAY; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DEVELOPMENT; HEMATOPOIETIC STEM CELL; HUMAN; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STEM CELL;

BIOTECHNOLOGY; HUMANS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84877799086     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2012.11.006     Document Type: Article

References (9)

1. Webb S. Burgeoning stem cell product market lures major suppliers. Nature Biotechnology 2010, 28:535-536.
2. GE Cytiva™ cardiomyocytes product information. GE Healthcare Life Sciences. http://www.gelifesciences.com/webapp/wcs/stores/servlet/catalog/en/GELifeSciences-UK/products/AlternativeProductStructure_16985/28976398.
3. Dykens J.A., Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today 2007, 12:777-785.
4. Hather C., Roquemore L., Thomas N. High-content analysis of a live multiplexed cytotoxicity study using Cytiva™ Cardiomyocytes and IN Cell Analyzer 2000. GE Healthcare Life Sciences Newsletter - Discovery Matters 2011, 13. http://gelifesciences.co.jp/newsletter/life_science_news/pdf/dm013_16.pdf.
5. BGI and GE Healthcare press release BGI, GE Healthcare team up on pioneering stem cell science projects 2012, http://www.genewscenter.com/News/BGI-GE-Healthcare-team-up-on-pioneering-stem-cell-science-projects-38f8.aspx.
6. National Cancer Institute SEER Cancer Statistics Review 1975-2009 2009, http://seer.cancer.gov/csr/1975_2009_pops09/results_merged/sect_18_myeloma.pdf.
7. National Marrow Donor Program; 2012. http://marrow.org/Home.aspx.
8. UCSF and GE Healthcare press release UCSF, GE Healthcare team up on pioneering cord blood project 2011, http://www.genewscenter.com/Press-Releases/UCSF-GE-Healthcare-team-up-on-pioneering-cord-blood-project-353d.aspx.
9. Karolinska University Hospital and GE Healthcare press release Karolinska University Hospital and GE Healthcare collaborate to advance technologies for cell therapy 2012, http://www.genewscenter.com/Press-Releases/Karolinska-University-Hospital-and-GE-Healthcare-collaborate-to-advance-technologies-for-cell-therapy-3892.aspx.